Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents

Details for Australian Patent Application No. 2007229301 (hide)

Owner Stem Cell Therapeutics Corp.

Inventors Weiss, Samuel; Gregg, Christopher; Tucker, Joseph; Davidoff, Allen

Agent Griffith Hack

Pub. Number AU-A-2007229301

PCT Pub. Number WO2007/106987

Priority 60/783,500 17.03.06 US; 60/862,669 24.10.06 US; 60/789,132 05.04.06 US

Filing date 16 March 2007

Wipo publication date 27 September 2007

International Classifications

A61K 38/24 (2006.01) Medicinal preparations containing peptides - Follicle-stimulating hormone (FSH)

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/106987 Priority application(s): WO2007/106987

1 September 2011 Alteration of Name

  The name of the applicant has been altered to Stem Cell Therapeutics Corp. Amendments 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007229309-Apparatus and method for welding

2007229300-Dosing regimes for LH or hCG and EPO for treatment of neurological disorders